Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis

E. Riva, E. Fossali, A. Bettinelli

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Furosemide was measured by gas-liquid chromatography in blood and dialysis fluid from 7 children with chronic renal failure, undergoing regular haemodialysis. It was administered chronically, in two or three daily doses (4.2-9.4 mg/kg). Two children received 1 mg/kg intravenously for determination of the pharmacokinetics. The half-life was longer than in adults and in anephric patients on haemodialysis. Systemic and renal clearance were also much lower. Plasma protein binding in 2 out of 6 cases was reduced as campared to normal adults. The data do not suggest any need to modify the present dosage schedule despite the 4-5 fold increase in the half-life of furosemide. The contribution of haemodialysis to drug clearance was minimal, and accounted for less than 10% of the total clearance.

Original languageEnglish
Pages (from-to)303-306
Number of pages4
JournalEuropean Journal of Clinical Pharmacology
Volume21
Issue number4
DOIs
Publication statusPublished - Jul 1982

Fingerprint

Furosemide
Chronic Kidney Failure
Renal Dialysis
Half-Life
Protein Binding
Gas Chromatography
Blood Proteins
Dialysis
Appointments and Schedules
Pharmacokinetics
Kidney
Pharmaceutical Preparations

Keywords

  • children
  • dosage schedule
  • furosemide
  • haemodialysis
  • pharmacokinetics
  • renal failure

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Cite this

Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis. / Riva, E.; Fossali, E.; Bettinelli, A.

In: European Journal of Clinical Pharmacology, Vol. 21, No. 4, 07.1982, p. 303-306.

Research output: Contribution to journalArticle

@article{a4deb0dddfd84b84b038c8685dfa8dcb,
title = "Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis",
abstract = "Furosemide was measured by gas-liquid chromatography in blood and dialysis fluid from 7 children with chronic renal failure, undergoing regular haemodialysis. It was administered chronically, in two or three daily doses (4.2-9.4 mg/kg). Two children received 1 mg/kg intravenously for determination of the pharmacokinetics. The half-life was longer than in adults and in anephric patients on haemodialysis. Systemic and renal clearance were also much lower. Plasma protein binding in 2 out of 6 cases was reduced as campared to normal adults. The data do not suggest any need to modify the present dosage schedule despite the 4-5 fold increase in the half-life of furosemide. The contribution of haemodialysis to drug clearance was minimal, and accounted for less than 10{\%} of the total clearance.",
keywords = "children, dosage schedule, furosemide, haemodialysis, pharmacokinetics, renal failure",
author = "E. Riva and E. Fossali and A. Bettinelli",
year = "1982",
month = "7",
doi = "10.1007/BF00637617",
language = "English",
volume = "21",
pages = "303--306",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis

AU - Riva, E.

AU - Fossali, E.

AU - Bettinelli, A.

PY - 1982/7

Y1 - 1982/7

N2 - Furosemide was measured by gas-liquid chromatography in blood and dialysis fluid from 7 children with chronic renal failure, undergoing regular haemodialysis. It was administered chronically, in two or three daily doses (4.2-9.4 mg/kg). Two children received 1 mg/kg intravenously for determination of the pharmacokinetics. The half-life was longer than in adults and in anephric patients on haemodialysis. Systemic and renal clearance were also much lower. Plasma protein binding in 2 out of 6 cases was reduced as campared to normal adults. The data do not suggest any need to modify the present dosage schedule despite the 4-5 fold increase in the half-life of furosemide. The contribution of haemodialysis to drug clearance was minimal, and accounted for less than 10% of the total clearance.

AB - Furosemide was measured by gas-liquid chromatography in blood and dialysis fluid from 7 children with chronic renal failure, undergoing regular haemodialysis. It was administered chronically, in two or three daily doses (4.2-9.4 mg/kg). Two children received 1 mg/kg intravenously for determination of the pharmacokinetics. The half-life was longer than in adults and in anephric patients on haemodialysis. Systemic and renal clearance were also much lower. Plasma protein binding in 2 out of 6 cases was reduced as campared to normal adults. The data do not suggest any need to modify the present dosage schedule despite the 4-5 fold increase in the half-life of furosemide. The contribution of haemodialysis to drug clearance was minimal, and accounted for less than 10% of the total clearance.

KW - children

KW - dosage schedule

KW - furosemide

KW - haemodialysis

KW - pharmacokinetics

KW - renal failure

UR - http://www.scopus.com/inward/record.url?scp=0019781059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019781059&partnerID=8YFLogxK

U2 - 10.1007/BF00637617

DO - 10.1007/BF00637617

M3 - Article

C2 - 7056274

AN - SCOPUS:0019781059

VL - 21

SP - 303

EP - 306

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 4

ER -